InvestorsHub Logo
Followers 12
Posts 1139
Boards Moderated 0
Alias Born 02/13/2018

Re: Blueheel1 post# 103535

Sunday, 08/09/2020 9:46:05 AM

Sunday, August 09, 2020 9:46:05 AM

Post# of 232517
The target is statistically significant. Good versus great is not determined in these trials. If the results show that leronlimab is better than standard of care, that’s a winner. Especially with what we’ve been shown from a safety perspective.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News